No Data
No Data
No Data
No Data
No Data
Sagaliam Acquisition Corp Launches Improved IPF Formula With Vitamin C in Pill and Lozenge Form and Addition of New Slimming Neutraceutical
BAYTOWN, TX / ACCESSWIRE / May 1, 2024 / Sagaliam Acquisition Corp announced today that Virogentics, Inc., a wholly owned subsidiary of SAGA ,
AccesswireMay 1 20:30
Sagaliam Acquisition Corp. Announces Novation Agreement With Enzolytics, Inc.
NEW YORK, NY / ACCESSWIRE / April 26, 2024 / Sagaliam Acquisition Corp. ("SAGAU", "SAGA", SAGAR") (the "Company") announced that Sagaliam entered into a Novation Agreement with Enzolytics, Inc. (OTC P
AccesswireApr 26 20:00
Sagaliam Acquisition Corp.'s Nasdaq Delisting and OTC Transition
TipRanksMar 7 22:52
SAGALIAM ACQUISITION CORP. ANNOUNCES DELISTING OF COMMON SHARES FROM NASDAQ
New York, NY, March 07, 2024 (GLOBE NEWSWIRE) -- Sagaliam Acquisition Corp. (NASDAQ: "SAGAU", "SAGA", SAGAR") (the "Company") received a Nasdaq Hearing Withdrawal letter ("Notice") from the Listing Qualifications staff
GlobeNewswireMar 7 22:35
Sagaliam Acquisition Corp. Receives Delisting Notification Letter From Nasdaq
Sagaliam Acquisition Corp. Receives Delisting Notification Letter From Nasdaq
BenzingaDec 12, 2023 06:17
Enzolytics Announces the Signing of the Business Combination Agreement With Sagaliam Acquisition Corp (SAGA)
COLLEGE STATION, TX / ACCESSWIRE / September 18, 2023 / Enzolytics, Inc. (OTC PINK:ENZC) (Enzolytics, Inc. announces today that it has executed the binding business combination agreement for the sale
AccesswireSep 18, 2023 20:00
No Data
No Data